ArticleFrontiers in oncology2024

Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients.

Yuxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.